Grok Pulse Nov 16, 2026 · 2 min read

$IREN stock call: Avoid until $14, buy zone $12 to $14

$IREN stock call: Avoid until $14, buy zone $12 to $14

$IREN: Avoid until $14. I'd buy between $12 and $14.

61% below its 200-day and worth about 1.7x the $4B run rate it says is already funded

I think the business is real but a $6B funding gap and a slipped deadline can push the stock lower first.

Not financial advice


The bear case: IREN moved its $4B annual run-rate target from year-end to January and said it may slip to the end of February after a Microsoft-requested design change and supplier delays. Management also said capital markets have become more selective while it reportedly still needs about $6B for the wider build. Nebius gave a weak outlook and IREN hit a new 52-week low of $16.01 today.


The chart: the rally ran from $5.13 in April 2025 to $76.87 last November. I count the fall since then as an A-B-C. A ended at $30.76 in March, B bounced to $70.71 in June and C reached $16.01 today. C at 1.272 times A is $12.05 and the 88.6% retrace of the whole rally is $13.30. The August 2025 low of $14.72 sits just above that.


The business is growing fast. Q1 revenue rose 66% from the prior quarter to $228M and AI cloud revenue nearly tripled to $200M. The backlog is $20.3B with about two-thirds from investment-grade customers. It still lost $263M in the quarter. Intel disclosed a 1.3M share stake in an SEC filing today.


My plan: I would not buy a stock falling this hard with this much money still to raise. I'd start buying between $12 and $14 and hold for years. A weekly close below $10 means my count is wrong and I'd wait. I would rather pay $13 after the funding is done than $16 before it.

Sources: IREN Q1 FY27 release (Nov 5 2026): revenue $228M +66% q/q, AI Cloud $200M, net loss $263M, backlog $20.3B, $4B ARR targe · QuantAbundance Q1 FY27 recap: AI cloud revenue nearly triples to $200M, $4B run rate slips to January · Investing.com (Nov 16): new 52-week low, ARR delay, ~$6B funding gap, 'more selective' capital markets, Nebius outlook, · StreetInsider (Nov 16): new 52-week low on funding concerns, $6B funding need, ARR target delay · MarketBeat (Nov 16): 52-week low, ARR milestone pushed to 2027, estimated $6B more financing · Reuters via TradingView: Intel reports 1.3M share stake in IREN

Not financial advice. For informational and educational purposes only.

Track your live portfolio alongside our daily institutional research

Connect your brokerage in 60 seconds and get full access to Position Tracker Substack research inside your dashboard.

Start your free trial →